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Liver transplantation and hepatobiliary surgery in 2020
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The year 2020 had a rough start with a global pandemic, the new
Coronavirus Disease (COVID-19). The impact was so severe for long-
time that many elective surgeries were cancelled, and numerous
transplants were postponed, unless truly life-saving. Despite these
hurdles in our daily practice, more than 100 expert academic physicians
and surgeons from 22 different countries joined forces to form a Special
Issue in Liver Transplantation and Hepatobiliary Surgery. This collec-
tion of 30 comprehensive articles, summarize the current status of liver
transplantation (LT) and hepatobiliary surgery today, and what limits
are being pushed and pursued in the future. One important goal of this
Special Issue is to emphasize the close relationship of LT and hepato-
biliary surgery, and how innovations in both fields align with one an-
other. This central principle is also mirrored by the fact that the col-
laboration for each article has been established under the umbrella of
both the International Society of Liver Surgeons (ISLS), and the
International Liver Transplantation Society (ILTS).
In order to highlight the geographic variability in recent LT prac-
tices around the globe, the current status of liver transplantation in Asia
[1], North America [2], Latin America [3], and Europe [4] have been
reviewed by international LT experts. With the aim to expand the donor
pool due to the shortage of transplantable livers, LT using marginal
donors (elderly livers, steatotic livers, donation after circulatory death
[DCD] livers, split livers) was extensively summarized [5]. Ongoing
debates in deceased donor LT (DDLT) were further discussed by experts
with particular focus on limits for an acceptable DCD graft [6], domino
LT [7], as well as the role of hypothermic [8] and normothermic ma-
chine perfusion [9]. The use of machine perfusion technology is en-
hancing DDLT practice, since liver grafts deemed non-transplantable
due to fatty or marginal nature were rescued and successfully trans-
planted with assistance of machine perfusion.
Another important focus of the Special Issue is dedicated to use of
LT and hepatobiliary surgery to treat primary and secondary liver
malignancies. The Milan criteria are the most commonly established
selection criteria for LT in patients with hepatocellular carcinoma
(HCC). A group of experts highlighted where we stand and what pre-
dictors we have when we perform LT in HCC patients beyond Milan
Criteria [10]. In this regard, emerging biomarkers in order to predict
HCC outcomes have also been highlighted [11]. One of the challenging
indications for LT, cholangiocarcinoma (CCA), and its multidisciplinary
treatment with or without LT has been reviewed with current devel-
opments in the field [12]. When LT is not a possibility in CCA, recently
emerging surgical approach ‘Associating liver partition and portal vein
ligation (ALPPS)’ for staged hepatectomy procedure could be life-saving
[13]. ALPPS has been mainly performed for colorectal liver metastasis,
and results have been steadily improving with better knowledge in how
to select patients and when to proceed with stage 2 surgery [14]. An-
other newly introduced and developing surgical approach is LT for
colorectal liver cancer metastasis [15]. A few years ago, this concept
was considered an absolute contraindication to LT. However, emerging
data appear to show that acceptable results can be achieved in high-risk
cancer recipients with LT, far superseding survival with non-surgical
approaches [15]. Although it is still experimental, the RAPID concept
(i.e. resection and partial liver segment 2–3 transplantation with de-
layed total hepatectomy) represents another surgical innovation uni-
fying elements of partial LT and ALPPS surgery in order to expand the
donor pool [16]. The RAPID concept will have a greater impact in living
donor LT (LDLT) by increasing the safety in living donors and providing
a sufficient liver volume despite the transplantation of segments 2–3.
With improving medical management of chronic liver failure, and the
shortage of transplantable liver grafts, many patients present late stage
for LT with high MELD (Model for End-stage Liver Disease) score and
chronic kidney disease. In fact, in the last decade the number of patients
requiring combined liver-kidney transplant (CLKT) has been steadily
increasing, now making 10% of all LTs in the United States [17]. An-
other staged surgical procedure ‘delayed kidney transplantation in
CLKT – Indiana Approach’ and other recent developments in CLKTs
have been comprehensively reviewed [17].
LDLT is more common than DDLT in Asia [1], and it has been in-
creasingly performed in Turkey, Europe [4] and other parts of the
world. However, many fine surgical techniques should be mastered, and
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many hurdles should be overcome in LDLT. Some ongoing discussions,
such as right lobe versus left lobe [18], and small-for-size setting [19] in
LDLT have been reviewed. The Achilles heels of LDLT, biliary re-
constructions and complications, have been also discussed with recent
evidences [20]. Although LDLT should be extensively planned in the
donor and recipient, there is an increasing evidence that it can be of-
fered for acute liver failure patients in an urgent setting with acceptable
results [21]. With expertise and surgical advancement in LDLT, mini-
mally invasive donor hepatectomy has been offered more often in order
to minimize morbidity in living donors [22].
Other challenging issues in both DDLT and LDLT recipients have
been broadly covered with particular attention to current management
of portal vein thrombosis (PVT) [23] and indications for multivisceral
transplantation when PVT cannot be managed either radiologically or
surgically [24]. Recent developments and challenges in hepatobiliary
surgery have been also extensively reviewed with particular attention
to extended liver surgery for gallbladder cancer [25], liver resections in
cirrhotic patients [26], laparoscopic major liver resections [27] with
laparoscopic postero-superior segment liver resections [28], robotic
liver resections [29], and parenchyma sparing liver resections [30].
We, the guest editors, are proud to present top reviews from this
global network of expert liver surgeons, making this Special Issue as
one of the top references in liver transplantation and hepatobiliary
surgery.
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